News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–20
Matches
20
Sources here
3
Companies here
1
Search results Stored financial headlines

Active search

20 matching headlines

Ticker or company: IQVHMain company stories
Clear
Latest

finance.yahoo.com Earnings

How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook

In late July and early August 2026, IQVIA Holdings and Medera announced a collaboration pairing IQVIA's global clinical and commercialization infrastructure with Medera's Sardocor and Novoheart cardiac gene therapy and human-based drug discovery platforms, alongside IQVIA's second-quarter results, raised full-year 2026 revenue guidance to between US$17.28 billion and US$17.48 billion, and continued share repurchases. The partnership's focus on …

Main company 🇦🇹 Austria
Read at finance.yahoo.com
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
finance.yahoo.com Deals and strategy Main company 🇦🇹 Austria

IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies

By Exec Edge Editorial Staff IQVIA (NYSE: IQV) and clinical-stage biopharmaceutical company Medera Inc. announced a strategic collaboration aimed at accelerating the development of cardiac gene therapies and human-based drug discovery platforms. Under the partnership, Medera's Sardocor unit will use IQVIA's clinical trial, regulatory …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Regulatory and legal Main company 🇦🇹 Austria

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

Medera Inc. RESEARCH TRIANGLE PARK, N.C. and BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Main company 🇦🇹 Austria

Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last

IQVIA Holdings Inc. IQV shares climbed 13% in a week as investors weighed better-than-expected quarterly results, stronger bookings and a raised full-year outlook. The move reflects improving operating momentum, but its durability depends on whether bookings convert into revenue and earnings while leverage remains …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

The Backlog Tells the Real Story: Inside IQVIA’s Blowout Q2

The global healthcare ecosystem in 2026 is leading to a strong recovery in clinical research, with global pharma R&D investment topping $250 billion and the clinical research organization (CRO) market rising to $72 billion at roughly a 9% annual pace. As biopharma companies move …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
nasdaq.com Earnings Main company 🇦🇹 Austria

An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know

Key Points The transaction involved the sale of 5,000 shares at $249.16 per share, representing a total value of about $1.2 million. This disposition resulted in a 19% reduction of the insider total direct equity holdings in the company. The sale was executed directly, …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

Chairman and CEO Ari Bousbib reported a sale of about 106,000 shares of IQVIA Holdings Inc. (NYSE:IQV) for total proceeds of $26.1 million in an SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$26.1 million Shares sold ~106,000 Post-transaction shares (total) ~1.4 …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Analyst action Main company 🇦🇹 Austria

IQVIA (IQV) Stock Sees Modest Fair Value Lift After Mixed Analyst Target Changes

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. IQVIA Holdings just saw its internal fair value price target move from US$226.95 to …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

IQVIA Holdings (IQV) Earnings Beat Keeps Fair Value In Focus

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. IQVIA Holdings (IQV) stock moved after the company reported second quarter results that exceeded analyst estimates, raised full year 2026 revenue and earnings guidance, …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

IQVIA (IQV) Shares Skyrocket, What You Need To Know

IQVIA (IQV) Shares Skyrocket, What You Need To Know What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 12.9% in the morning session after the company reported second-quarter results that surpassed Wall Street's expectations and raised its full-year guidance. The company posted …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2

IQVIA Holdings Inc. (NYSE:IQV) extended its winning streak to a 4th straight session on Tuesday, jumping 13.94 percent to finish at $242.94 apiece after its higher revenue growth outlook and strong second-quarter performance reinforced investor confidence in its growth trajectory. In an updated report, …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
nasdaq.com Earnings Main company 🇦🇹 Austria

IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

IQVIA Holdings (IQV) reported $4.37 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 8.7%. EPS of $3.15 for the same period compares to $2.81 a year ago. The reported revenue represents a surprise of +1.63% over the Zacks …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

IQVIA Holdings Inc (IQV) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven ...

This article first appeared on GuruFocus. Total Revenue: $4,368 million, up 8.7% on a reported basis and 8.5% at constant currency. Commercial Solutions Revenue: $1,793 million, up 8.6% on a reported basis and 8.4% at constant currency. R&D Solutions Revenue: $2,575 million, up 8.8% …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Guidance Main company 🇦🇹 Austria

Clinical Trials Provider Soars, Clears Buy Point On Solid Q2 Results

Shares of Iqvia surged past a buy point Tuesday after the provider of clinical research services beat second-quarter estimates and raised guidance. The consensus earnings estimate was $3.03 per share, with the highest estimate at $3.08, according to FactSet. The backlog for its Research …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

IQVIA’s (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars

IQVIA's (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars Clinical research company IQVIA (NYSE: IQV) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 8.7% year on year to $4.37 billion. The company's full-year revenue guidance of $17.38 billion at the midpoint …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
seekingalpha.com Earnings Main company 🇦🇹 Austria

IQVIA Non-GAAP EPS of $3.15 beats by $0.12, revenue of $4.37B beats by $70M

* IQVIA press release [https://seekingalpha.com/pr/20597017-iqvia-reports-second-quarter-2026-results] (IQV [https://seekingalpha.com/symbol/IQV]): Q2 Non-GAAP EPS of $3.15 beats by $0.12. * Revenue of $4.37B (+8.7% Y/Y) beats by $70M. * Commercial Solutions Revenue $1,793 million, up 8.6% year-over-year * R&D Solutions Revenue $2,575 million, up 8.8% year-over-year * R&D …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

IQVIA Reports Second-Quarter 2026 Results

Revenue $4,368 million, up 8.7% year-over-year GAAP Net Income $256 million, Adjusted EBITDA $994 million, up 9.2% year-over-year GAAP Diluted Earnings per Share $1.53, Adjusted Diluted Earnings per Share $3.15, up 12.1% year-over-year Commercial Solutions Revenue $1,793 million, up 8.6% year-over-year R&D Solutions Revenue …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow

Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before market hours. Here's what you need to know. IQVIA beat analysts' revenue expectations last quarter, reporting revenues of $4.15 billion, up 8.4% …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

The market expects IQVIA Holdings (IQV) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …

IQVH main company
Sharemaestro market context Trend signal active 52 weeks +26.0% IQVH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context